Neuraxis, Inc. (NRXS) stock news · rev $3.6M
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
This NRXS news page leads with what Neuraxis, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for NRXS yet. We will not pad this page with generic market recap.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NRXS stock page; for the tape open the quote page.
NRXS stock news FAQ
What are NRXS's latest revenue and net income?
Latest cached Neuraxis, Inc. (NRXS) revenue for Dec 31, 2025 was $3.6M. Net income was -$7.8M. Statements: https://lician.com/financials/nrxs
How did NRXS revenue change from the prior cached period?
Cached Neuraxis, Inc. (NRXS) revenue was up 32.9% from $2.7M (Dec 31, 2024) to $3.6M (Dec 31, 2025). Statements: https://lician.com/financials/nrxs
What is NRXS's market cap?
Neuraxis, Inc. (NRXS) market cap is $83.1M on the latest cached fundamentals snapshot.
What kind of company is NRXS?
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Where is NRXS stock news listed?
Cached stock news for Neuraxis, Inc. (NRXS) is listed at https://lician.com/news/nrxs. Filings: https://lician.com/sec/nrxs
Not investment advice.